Australia Stock Exchange release from MEMPHASYS : Acceleration of reproductive biotechnology portfolio
19/09/2021 23:22
Australia Stock Exchange release from MEMPHASYS MEM.AX : Acceleration of reproductive biotechnology portfolio
Recent news on Memphasys
See all newsBrief: Memphasys Receives A$3.5 Million From Peters Investments
Brief: Memphasys Says Potential Expedited FDA Pathway To US IVF Market
Brief: Memphasys Secures 3-Year Felix Agreement With Invido For A$674,000 Minimum Purchases
Australia's Memphasys soars on signing exclusive commercialisation agreement with NOVIVITAE
Brief: Memphasys Says Vietnamese Registration For Felix System Has Been Achieved In August 2026